Announce Date | 07/23/2025 |
EPS Normalized Actual | $0.81 (Beat by $0.143) |
EPS GAAP Actual | $0.81 (Beat by $0.143) |
Revenue Actual | $5.6503B |
Revenue Surprise | Beat by $5650.3M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.914 |
EPS GAAP Estimate | $0.914 |
Revenue Estimate | $3.543378431B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.26569 | 19.81 | 5.01562 | 5.58952 | 2 |
Dec 2026 | 4.09238 | 25.49 | 3.6 | 4.69864 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.9 | 0.0025000000000001 | 5.6503B | 36.11% | 2162.4M |
FQ1 2025 (Mar 2025) | 0.61 | 0.61 | 4.811B | 32.32% | 4811M |
FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 4.3179B | 22.94% | 4317.9M |
FQ3 2024 (Sep 2024) | 1.19 | 1.19 | 4.0389B | 20.79% | 4038.9M |
FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 3.6097B | 15.4% | 3609.7M |
FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 3.2563B | 8.67% | 3256.3M |
FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 3.3275B | 2.66% | 3327.5M |
FQ3 2023 (Sep 2023) | 0.86 | 0.86 | 3.1992B | -3% | 3199.2M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.914
Consensus Revenue Estimates
3.543378431B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.86737 | -- | 0.80513 | 0.92525 | 6 |
FQ3 2027 (Sep 2027) | 0.7101 | -- | 0.68866 | 0.74112 | 2 |
FQ2 2027 (Jun 2027) | 0.6693 | -- | 0.64909 | 0.69854 | 2 |
FQ1 2027 (Mar 2027) | 0.63392 | -- | 0.60315 | 0.66835 | 2 |
FQ4 2026 (Oct 2026) | 1.0831 | -- | 1.05288 | 1.11124 | 3 |
FQ3 2026 (Jul 2026) | 1.0031 | -- | 0.97511 | 1.02916 | 3 |
FQ2 2026 (Jun 2026) | 0.54491 | -65.16 | 0.52322 | 0.5608 | 4 |
FQ1 2026 (Mar 2026) | 0.51739 | -17.9 | 0.4968 | 0.53247 | 4 |
FQ4 2025 (Oct 2025) | 0.98 | 36.73 | 0.95266 | 1.00546 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 6.18B | -- | 5.83B | 6.49B | 7 |
FQ3 2027 (Sep 2027) | 5.2B | -- | 5.08B | 5.37B | 3 |
FQ2 2027 (Jun 2027) | 4.94B | -- | 4.83B | 5.11B | 3 |
FQ1 2027 (Mar 2027) | 4.79B | -- | 4.61B | 4.99B | 3 |
FQ4 2026 (Oct 2026) | 4.02B | -- | 3.93B | 4.1B | 4 |
FQ3 2026 (Jul 2026) | 3.81B | -- | 3.73B | 3.88B | 4 |
FQ2 2026 (Jun 2026) | 4.21B | -34.06 | 4.09B | 4.31B | 3 |
FQ1 2026 (Mar 2026) | 4.02B | -19.67 | 3.9B | 4.11B | 3 |
FQ4 2025 (Oct 2025) | 3.73B | -15.65 | 3.65B | 3.81B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.8975 | 0.9 | 0.0025000000000001 | 0.28% |
FQ1 2025 (Mar 2025) | 0.61 | 0.61 | 100% | |
FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 100% | |
FQ3 2024 (Sep 2024) | 1.19 | 1.19 | 100% | |
FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 100% | |
FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 100% | |
FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 100% | |
FQ3 2023 (Sep 2023) | 0.86 | 0.86 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $3.49B | $5.65B | $2162.4M | 38.27% |
FQ1 2025 (Mar 2025) | $0B | $4.81B | $4811M | 100% |
FQ4 2024 (Dec 2024) | $0B | $4.32B | $4317.9M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.04B | $4038.9M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.61B | $3609.7M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.26B | $3256.3M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.33B | $3327.5M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.2B | $3199.2M | 100% |